Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715959 · ClinicalTrials.gov registry record · NA
Nipple Aspirate Fluid in Detecting Breast Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03715959: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT03715959 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03715959, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This trial studies nipple aspirate fluid in detecting breast cancer. Nipple aspirate fluid may better detect breast cancer earlier than current methods used for screening such as mammograms and breast examinations.
Primary Outcome
Nipple aspiration fluid samples will be compared between breast cancer participants and healthy participants. will perform the logistic regression model for each biomarker that shows any difference between the breast cancer patients and healthy individuals. Then we will include multiple biomarkers in one model while controlling for confounders.
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Aspiration of Breast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2024-01-01 |
| Phase | NA |
What the finished NCT03715959 record still lists
NCT03715959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT03715959 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03715959 about?
NCT03715959 is a clinical study titled "Nipple Aspirate Fluid in Detecting Breast Cancer". This trial studies nipple aspirate fluid in detecting breast cancer. Nipple aspirate fluid may better detect breast cancer earlier than current methods used for screening such as mammograms and breast examinations.
What is the current status of trial NCT03715959?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2020-12-10. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT03715959?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Aspiration of Breast (PROCEDURE).
Who is sponsoring clinical trial NCT03715959?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03715959's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI